Severe COVID-19: what have we learned with the immunopathogenesis?

Area of Science:

• Immunology
• Virology
• Pathogenesis

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge.
• Severe disease is increasingly linked to the host's immune response rather than viral load alone.
• Understanding the immunopathogenesis of SARS-CoV-2 is crucial for developing effective treatments.

Purpose of the Study:

• To present a theoretical model of immunopathogenesis in severe COVID-19.
• To synthesize current literature on SARS-CoV-2, SARS, and MERS concerning immune responses.
• To highlight the role of immune dysregulation in severe COVID-19 outcomes.

Main Methods:

• Narrative review of existing scientific literature.
• Analysis of studies on SARS-CoV-2, SARS, and MERS.
• Theoretical modeling of immune responses in severe COVID-19.

Main Results:

• Immune dysregulation, including delayed interferon response and lymphocyte exhaustion, contributes to severe COVID-19.
• Cytokine storms are a key feature, leading to lung damage and thrombotic events.
• The virus SARS-CoV-2 triggers hyperinflammation, exacerbating disease severity.

Conclusions:

• Immune dysregulation and hyperinflammation are central to severe COVID-19 pathogenesis.
• Further research into SARS-CoV-2 immunopathogenesis is needed to guide clinical strategies.
• Developing treatments targeting immune responses may be key to managing severe COVID-19.